+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition



Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition



Oncology Reports 26(2): 455-461



A small subset of cells within a malignant neoplasm, named cancer stem cells (CSCs) or tumour initiating cells, are thought to be capable of initiating the neoplasm itself, and of driving its growth and recurrence after treatment. It is unclear whether CSCs can be identified and experimentally induced within oral squamous cell carcinoma (OSCC), although this has been reported for a number of other tumour types. In this study, we aimed to determine whether BMP-4 (bone morphogenetic protein-4) could induce epithelial-mesenchymal transition (EMT) with acquisition of stem cell-like phenotypes in a cell-culture model. Furthermore, the differential expression of ABCG2, a putative CSC marker, was determined in human normal oral mucosa and OSCC tissues at mRNA and protein level. The results showed that after treatment with BMP-4, most Tca8113 cells (a human tongue OSCC cell line) changed their morphology from slabstone to spindle-shaped, and demonstrated enhanced expression of ABCG2 compared with non-treated cells. Expression of Oct-4 was induced in cell nuclei with up-regulation of EMT markers (Snail, Slug and vimentin), and down-regulation of E-cadherin. Interestingly, the expression of hTERT, CD44 and Bmi-1 (generally accepted as markers of CSCs) were up-regulated, but this was not synchronous with the expression of EMT markers. Tumour spheres were formed after stimulation with BMP-4, with high expression of CD44 and ABCG2. In human tissues, ABCG2 was strongly expressed in OSCC, but not in normal mucosa. This study suggests that BMP-4-mediated EMT constitutes one possible pathway for the development of CSCs in oral cancer, implying a transient therapeutic opportunity if EMT can be interrupted early in the evolution of such a neoplasm.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052640535

Download citation: RISBibTeXText

PMID: 21567100

DOI: 10.3892/or.2011.1299


Related references

EGF/TGFβ1 co-stimulation of oral squamous cell carcinoma cells causes an epithelial-mesenchymal transition cell phenotype expressing laminin 332. Journal of Oral Pathology and Medicine 40(1): 46-54, 2011

MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro. International Journal of Oncology 47(4): 1339-1350, 2015

Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma. International Journal of Oncology 49(5): 1859-1869, 2016

Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. International Journal of Oncology 29(5): 1133-1138, 2006

Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44 high cells. Pathology Research and Practice 213(3): 235-244, 2017

Hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma. International Journal of Molecular Medicine 40(1): 83-89, 2017

MicroRNA-1258, regulated by c-Myb, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting SP1 in oral squamous cell carcinoma. Journal of Cellular and Molecular Medicine 23(4): 2813-2821, 2019

Epithelial to mesenchymal transition induces stem cell like phenotype in renal cell carcinoma cells. Cancer Cell International 18: 57, 2018

Epigenetic regulators governing cancer stem cells and epithelial-mesenchymal transition in oral squamous cell carcinoma. Current Stem Cell Research and Therapy 10(2): 140-152, 2015

ANXA1 affects cell proliferation, invasion and epithelial-mesenchymal transition of oral squamous cell carcinoma. Experimental and Therapeutic Medicine 14(5): 5214-5218, 2017

Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes. International Journal of Oncology 44(4): 1302-1308, 2014

Single cell migration in oral squamous cell carcinoma - possible evidence of epithelial-mesenchymal transition in vivo. Journal of Oral Pathology and Medicine 44(9): 674-679, 2015

CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma. Oncotarget 8(56): 95632-95647, 2017

Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma. Biochemical and Biophysical Research Communications 507(1-4): 142-147, 2018

Effects of irradiation on radioresistance, HOTAIR and epithelial-mesenchymal transition/cancer stem cell marker expression in esophageal squamous cell carcinoma. Oncology Letters 13(4): 2751-2757, 2017